Strides Receives Us Fda Approval For Generic Neoral Capsules

Strides Receives Us Fda Approval For Generic Neoral Capsules

By, Admin 4 August 2022

Strides Pharma Science Limited (Strides) Announced That Its Step-Down Wholly Owned Subsidiary, Strides Pharma Global Pte Limited, Singapore, Has Received Approval For Cyclosporine Softgel Capsules Usp (Modified), 25 Mg, 50 Mg, And 100 Mg From The United States Food & Drug Administration (Fda).The Product Is Bioequivalent And Therapeutically Equivalent To The Reference Listed Drug (Rld), Neoral Capsules 25 Mg, 50 Mg, And 100 Mg, Of Novartis Pharmaceuticals Corporation.Cyclosporine Softgel Capsules Is Part Of Strides Niche Product Portfolio With Limited Competition In The Us Market. Strides Is The First Indian Company To Get Approval For The Product. The Approval Further Strengthens Strides Immunosuppressant Portfolio For The Us Markets Which Now Comprises Of Mycophenolate Mofetil Tablets And Capsules, Tacrolimus Capsules And Cyclosporine Softgel Capsules.According To Iqvia Mat Data, The Us Market For Cyclosporine Capsules Usp, 25 Mg, 50 Mg, And 100 Mg Is Approximately Us$ 91 Million. The Product Will Be Manufactured At The Company

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!